![Rainer Boehm](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rainer Boehm
Director/Board Member at
OMEA THER
Net worth: - $ as of 30/09/2026
Profile
Rainer J.
Boehm is the founder of Rainer Boehm GmbH.
Current jobs include Chairman at Berlin Cures Holding AG since 2022, Independent Director at Omega Therapeutics, Inc. since 2022, and Director at BioCopy AG since 2020.
Former jobs include Chief Executive Officer & Head-Pharma Division at Novartis Pharma SAS, Independent Director at Nordic Nanovector ASA from 2018 to 2022, Independent Director at Humanigen, Inc. from 2018 to 2024, Independent Director at Cellectis SA from 2017 to 2026, Executive Vice President-North America at Novartis Oncology, Inc. from 2005 to 2010, and Chief Commercial & Medical Affairs Officer at Novartis Pharma Schweiz AG from 2010 to 2017.
Education includes a doctorate from Universität Ulm and an MBA from Schiller International University (France).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CELLECTIS S.A. -.--% | 15/02/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
Rainer Boehm active positions
| Companies | Position | Start |
|---|---|---|
| OMEA THER | Director/Board Member | 01/09/2022 |
Rainer Boehm GmbH | Founder | - |
BioCopy AG
 BioCopy AG BiotechnologyHealth Technology Discovers and develops biotherapeutic drugs using an automated, AI-assisted end-to-end platform | Director/Board Member | 01/02/2020 |
Berlin Cures Holding AG
 Berlin Cures Holding AG BiotechnologyHealth Technology Manufactures autoantibodies | Chairman | - |
Former positions of Rainer Boehm
| Companies | Position | End |
|---|---|---|
| CELLECTIS S.A. | Director/Board Member | 25/06/2026 |
| HUMANIGEN, INC. | Director/Board Member | 01/02/2024 |
| THOR MEDICAL | Director/Board Member | 28/04/2022 |
Novartis Pharma Schweiz AG
 Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Researches and develops vaccines for viral diseases | Chief Tech/Sci/R&D Officer | 01/01/2017 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | 01/01/2010 |
Education of Rainer Boehm
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
63
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Humanigen, Inc.
 Humanigen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in development of cell and gene therapies for treatment of cancers and infectious diseases | Health Technology |
Novartis Pharma Schweiz AG
Novartis Pharma Schweiz AG Miscellaneous Commercial ServicesCommercial Services Researches and develops vaccines for viral diseases | Commercial Services |
Cellectis SA
 Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
Universität Ulm
 Universität Ulm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharma SAS
 Novartis Pharma SAS Pharmaceuticals: MajorHealth Technology Develops gene therapies for patients with rare and life-threatening neurological genetic diseases | Health Technology |
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Develops innovative anticancer therapeutics | Health Technology |
Schiller International University (France)
 Schiller International University (France) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Omega Therapeutics, Inc.
 Omega Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for general and rare genetic diseases, immunology, inflammation, oncology and metabolic diseases | Health Technology |
Berlin Cures Holding AG
Berlin Cures Holding AG BiotechnologyHealth Technology Manufactures autoantibodies | Health Technology |
Rainer Boehm GmbH | |
BioCopy AG
BioCopy AG BiotechnologyHealth Technology Discovers and develops biotherapeutic drugs using an automated, AI-assisted end-to-end platform | Health Technology |
- Stock Market
- Insiders
- Rainer Boehm
